Bacmid expression of granulovirus enhancin En3 accumulates in cell soluble fraction to potentiate nucleopolyhedrovirus infection

dc.contributor.authorRicarte Bermejo, Adriana
dc.contributor.authorSimón de Goñi, Oihane
dc.contributor.authorFernández González, Ana Beatriz
dc.contributor.authorWilliams, Trevor
dc.contributor.authorCaballero Murillo, Primitivo
dc.contributor.departmentInstitute for Multidisciplinary Research in Applied Biology - IMABen
dc.date.accessioned2021-11-11T09:46:54Z
dc.date.available2021-11-11T09:46:54Z
dc.date.issued2021
dc.descriptionIncluye material complementarioes_ES
dc.description.abstractEnhancins are metalloproteinases that facilitate baculovirus infection in the insect midgut. They are more prevalent in granuloviruses (GVs), constituting up to 5% of the proteins of viral occlusion bodies (OBs). In nucleopolyhedroviruses (NPVs), in contrast, they are present in the envelope of the occlusion-derived virions (ODV). In the present study, we constructed a recombinant Autographa californica NPV (AcMNPV) that expressed the Trichoplusia ni GV (TnGV) enhancin 3 (En3), with the aim of increasing the presence of enhancin in the OBs or ODVs. En3 was successfully produced but did not localize to the OBs or the ODVs and accumulated in the soluble fraction of infected cells. As a result, increased OB pathogenicity was observed when OBs were administered in mixtures with the soluble fraction of infected cells. The mixture of OBs and the soluble fraction of Sf9 cells infected with BacPhEn3 recombinant virus was ~3- and ~4.7-fold more pathogenic than BacPh control OBs in the second and fourth instars of Spodoptera exigua, respectively. In contrast, when purified, recombinant BacPhEn3 OBs were as pathogenic as control BacPh OBs. The expression of En3 in the soluble fraction of insect cells may find applications in the development of virus-based insecticides with increased efficacy.en
dc.description.sponsorshipThis study received financial support from the Spanish Ministry project AGL2017-83498-C2-1-R. Bioinsectis SL funded the activities of ABF.es_ES
dc.format.extent17 p.
dc.format.mimetypeapplication/pdfen
dc.format.mimetypeapplication/zipen
dc.identifier.doi10.3390/v13071233
dc.identifier.issn1999-4915 (Electronic)
dc.identifier.urihttps://academica-e.unavarra.es/handle/2454/41032
dc.language.isoengen
dc.publisherMDPIen
dc.relation.ispartofViruses 2021, 13, 1233es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/AGL2017-83498-C2-1-R/ES/
dc.relation.publisherversionhttps://doi.org/10.3390/v13071233
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectAlphabaculovirusen
dc.subjectBetabaculovirusen
dc.subjectEnhancinsen
dc.subjectAcMNPV recombinanten
dc.subjectSpodoptera exiguaen
dc.subjectPotentiation of pathogenicityen
dc.titleBacmid expression of granulovirus enhancin En3 accumulates in cell soluble fraction to potentiate nucleopolyhedrovirus infectionen
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication
relation.isAuthorOfPublication2d9a4a11-cb33-4712-8860-74cd203cd53d
relation.isAuthorOfPublication5b9012ab-c911-4ef7-9a92-0041bc07bc6f
relation.isAuthorOfPublication8109ee0c-6969-4db1-b5e3-846b2466b2c6
relation.isAuthorOfPublication0b5a3470-9d73-4ac7-a923-c4f6079df358
relation.isAuthorOfPublicationecde8e03-14c2-46a3-9e89-ae3b2c668297
relation.isAuthorOfPublication.latestForDiscovery2d9a4a11-cb33-4712-8860-74cd203cd53d

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ricarte_BacmidExpression.pdf
Size:
2.33 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: